Luxonus develops medical imaging devices based on photoacoustic technology to produce super-high-resolution 3D images of blood vessels and lymphatic vessels without ionizing radiation. Its systems aim to provide safe, non-invasive visualization to improve diagnostic accuracy, aid surgical planning and enable early assessment of pharmacological effects. The company targets clinicians, hospitals and researchers in cardiovascular, lymphatic and oncology fields seeking improved imaging for treatment selection and outcome monitoring.
Health Care
Medical Devices
Medical Imaging
Lily MedTech is a spin-off of the University of Tokyo that develops a medical imaging device for breast cancer. Its device captures whole-breast three-dimensional images without direct contact, pain, or ionizing radiation. The company aims to commercialize this contactless 3D breast imaging technology for breast cancer screening and diagnosis in hospitals, clinics, and screening centers.
Health Care
Medical Devices
Medical Imaging
Riverfield is a Tokyo-founded medical robotics company spun out of the Tokyo Institute of Technology and Tokyo Medical and Dental University that develops pneumatically driven surgical robots. Its systems use pneumatic actuation to deliver delicate force control and intrinsic mechanical safety for precise, compact surgical instruments that assist surgeons in operative procedures. The company targets healthcare providers in aging societies facing surgeon shortages and aims to commercialize Made in Japan next-generation surgical robots to improve patient quality of life and operative efficiency.
Robotics
Medical Devices
Medical & Healthcare Robotics
Rege Nephro is a Japanese biotechnology company developing cell therapies to treat chronic kidney disease using nephron progenitor cells differentiated from induced pluripotent stem (iPS) cells. It is developing nephron progenitor cell-based regenerative products intended to restore nephron function and reduce or eliminate patients' dependence on dialysis. The company targets the large chronic kidney disease patient population in Japan and internationally, aiming to offer a curative alternative to lifelong dialysis through advanced regenerative medicine.
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Unifa is a Japan-based childcare‑tech company that develops IoT- and AI-enabled software and services for daycare centers and other early childhood care providers, including the Lookmee video monitoring system. Its product portfolio spans 12 services across healthcare, photography and ICT and is offered as a vertical SaaS suite designed to reduce childcare professionals' workload and improve the quality of childcare. Unifa has deployed its services at over 11,000 facilities across Japan and completed a ¥4.0 billion funding round in June 2021 while preparing for a future public listing.
Education
Digital Health
Internet of Things
Ubie develops an AI health assistant that guides patients to appropriate medical care based on their symptoms. It also provides digital tools to improve clinical efficiency, including symptom checkers and intake/triage solutions for medical practices. Ubie primarily serves patients and healthcare providers in Japan with the goal of expanding access to suitable medical care through technology.
Health Care
Digital Health
Medical AI
Melody International develops IoMT and e‑Health solutions for perinatal care, focusing on fetal monitoring and maternal health. The company makes an ultra-compact fetal monitor called Fetal Monitor iCTG and operates the perinatal e-Health platform Melody i to enable remote monitoring and telemedicine for pregnant women. Melody International serves hospitals, clinics and underserved populations in Japan and in developing countries to improve access to safe childbirth where specialists are scarce.
Women’s Health
Digital Health
Medical Devices
MELTIN MMI develops avatar robots and cyborg-related technologies by combining biosignal processing, brain–machine interface research and robotic engineering. The company commercializes medical devices and teleoperated avatar robots for remote communication, assistance and physical augmentation, serving healthcare, caregiving and telepresence markets. MELTIN MMI aims to extend human physical capabilities by integrating biological signal processing with embodied robots to enable remote embodiment and assistive applications.
Robotics
Medical Devices
Exoskeletons & Wearable Robotics
Medmain develops cloud-based digital pathology and AI diagnostic products that enable remote analysis of whole-slide images. Its flagship platform PidPort operates as a marketplace and workflow system combining deep-learning diagnostic modules and telepathology tools to support pathologists and automate histopathology interpretation. The company targets hospitals, diagnostic laboratories and healthcare networks in Japan and overseas to reduce wait times and address shortages of pathologists.
Diagnostics
Artificial Intelligence
Medical Imaging
MEDCOM develops an ICT healthcare platform to digitize clinical workflows and communications for medical institutions in Japan. Its flagship offering, the MEDCOM smartphone service, provides secure networked communication and workflow tools designed to support doctors and nurses and promote digital transformation and work-style reform in hospitals. The service is adopted nationwide and is used by over 50,000 healthcare professionals.
Health Care
Software
Digital Health
Metcela is a Japanese pre-clinical stage biotechnology company developing cell therapies for heart failure. The company is developing a clinically oriented cell therapy product called VCF intended to treat chronic heart failure. It aims to address the increasing burden of heart failure driven by aging and lifestyle diseases by delivering a regenerative alternative to current symptomatic treatments.
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
mediVR develops virtual reality-based rehabilitation systems to improve trunk balance and walking ability for patients with gait impairments in aging societies. Its core product is a tailor-made dual-task rehabilitation program that integrates immersive virtual reality, three-dimensional motion tracking, and artificial intelligence to deliver individualized training and objective assessment. The company targets hospitals, rehabilitation centers and healthcare providers seeking fall-prevention and functional recovery solutions for older adults and neurological patients.
Physical Therapy
Health Care
AR & VR
Metabologenomics is a joint venture founded by researchers from Keio University and Tokyo Institute of Technology that develops gut-environment assessment tools to enable personalized gut design aimed at disease prevention. It analyzes individuals' stool samples using its proprietary Metabologenomics technique to profile the gut environment and support stratified healthcare and medical care based on gut environment types. In May 2019 the company launched a Next-Generation Gut Environment Assessment Service for corporate and clinical customers using an original stool sampling kit.
Biotechnology
Digital Health
Genomics
Megakaryon develops platelet products manufactured from induced pluripotent stem (iPS) cells to provide a stable, donation-independent source for transfusion medicine. The company engineers protocols and scalable manufacturing techniques to produce safe, low-cost platelets for clinical transfusion and related cell-therapeutic applications. Megakaryon collaborates with academic institutions and industry partners to advance clinical translation and supply hospitals and blood services domestically and internationally.
Biotechnology
Pharmaceuticals
Cell & Gene Therapy
Magic Shields develops mechanical metamaterial-based protective products and has created Coroyawa, a material that stays firm under normal conditions but becomes soft on impact to cushion falls. Coroyawa is supplied as flooring and mats designed to reduce bone fractures among elderly people in care and residential environments. Magic Shields also integrates IoT monitoring and business support services with Coroyawa installations to detect falls and support care providers.
Manufacturing
Medical Devices
Advanced Materials
Alivexis is a technology-driven drug discovery company developing small-molecule therapeutics for oncology, chronic inflammation and immune disorders, and rare genetic diseases. The company integrates unique core biology insights with a supercomputer-powered discovery platform and scalable networked operations to advance its proprietary programs and collaborative projects. It operates offices in Tokyo and Boston and focuses on efficient delivery of breakthrough medicines for patients with unmet medical needs.
Biotechnology
Pharmaceuticals
Drug Discovery
MICIN is a Tokyo-based medical technology company that provides telemedicine platforms and digital health services to medical institutions and pharmacies in Japan. The company develops digital therapeutics (DTx) and digital solutions for decentralized clinical trials (DCT), serving healthcare providers and life sciences organizations. In 2021 it established a small-amount and short-term insurance company to expand into new insurance services alongside its healthcare platform offerings.
Insurance
Software
Digital Health
Holoeyes creates cloud-based software that converts medical imaging (DICOM) into interactive 3D models and visualizations for use in virtual and augmented reality. Its products support surgical planning, preoperative simulation, and medical education by enabling clinicians to inspect patient anatomy and collaborate in immersive environments. Holoeyes primarily serves hospitals, surgeons, medical device companies and academic institutions in Japan and abroad.
Software
Medical Imaging
AR & VR
Braizon Therapeutics develops biopharmaceutical therapeutics, focusing on innovative biologics and targeted treatments for oncology and other serious diseases. The company applies proprietary antibody engineering and drug-delivery platforms to generate therapeutic candidates and advance them through preclinical and clinical development. Braizon targets global pharmaceutical and healthcare markets through direct development, strategic partnerships, and licensing collaborations.
Biotechnology
Pharmaceuticals
Drug Discovery
VLP Therapeutics Japan is a Tokyo-based subsidiary of US-based VLP Therapeutics that was founded in 2020 by Dr. Wataru Akahata. The company conducts research and development of novel COVID-19 vaccines using VLP Therapeutics' proprietary self-amplifying (replicon) RNA technology to design and produce vaccine candidates. It operates in the Japanese and international infectious disease vaccine market and collaborates with research and funding agencies such as the Japan Agency for Medical Research and Development (AMED) to advance preclinical and clinical development.
Biotechnology
Pharmaceuticals
Vaccines
Fermata is a Tokyo- and Singapore-based company that operates an e-commerce marketplace and provides market-entry and consulting services focused on women's health and femtech across Southeast Asia and the broader APAC region. It curates and sells high-quality women's health products on its platform, organises events to build awareness of femtech, and creates market opportunities for startups. Fermata also advises corporate clients on market entry strategy, partnerships and commercialisation to support expansion into women's health and wellbeing sectors.
Commerce
Women’s Health
Marketplaces
Peace of Mind is a Japanese medical technology company based in Kumamoto that develops noninvasive neuromodulation devices for pain management. The company is developing a novel pain‑management device that applies a weak alternating magnetic field to produce analgesic effects reported in nonclinical and clinical studies, with the aim of delivering drug‑equivalent pain relief without systemic side effects. Peace of Mind targets clinical pain indications and broader central nervous system applications and is part of Japan's METI J-Startup program.
Health Care
Medical Devices
Himuka AM Pharma develops drug candidates derived from adrenomedullin (AM), a bioactive peptide originally discovered at the University of Miyazaki. The company focuses on creating peptide derivatives and drug seeds intended to address unmet medical needs in vascular, inflammatory and organ-protective conditions. It is a Japanese biotechnology company developing AM-based therapeutics for clinical and pharmaceutical markets.
Health Care
Clinical Research
Pharmaceuticals
Nanoegg Research Laboratories is a Japanese research spinoff from a medical university that specializes in dermatological science and drug-delivery technology. It develops proprietary delivery materials such as Nanocube and Moisturecube and commercializes pharmaceuticals, functional cosmetics, cosmetic materials and research reagents. The company markets skincare lines including the firming Horei, brightening Siroe White and MediQOL products formulated for sensitive and recurrent skin conditions, serving medical, cosmetic and research markets in Japan and internationally.
Drug Discovery
Pharmaceuticals
Cosmetics & Makeup
Triple W Japan develops and markets DFree, a wearable ultrasound-based device that monitors bladder size and predicts the optimal time to use the toilet. The device pairs with a smartphone app to deliver alerts and bladder-change data, aiming to reduce reliance on diapers and ease anxiety for people with urinary incontinence, dementia patients, and their caregivers in home and institutional care. Triple W Japan targets healthcare and eldercare markets in Japan and internationally, positioning DFree as an assistive IoT solution for remote monitoring and independent living.
Health Care
Digital Health
Medical Devices
Toregem BioPharma develops regenerative dental therapies that promote growth of tooth buds (tooth germs) by using neutralizing anti-USAG-1 antibodies, a negative regulator of tooth development. The company aims to restore missing teeth in patients with congenital tooth loss and to regenerate the tertiary dental lamina to improve oral function in elderly patients. Toregem targets regenerative dentistry and oral healthcare markets by advancing biologic therapeutics to extend healthy lifespans through restoration of dental structures.
Health Care
Pharmaceuticals
Dental Care
ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support life-science research, diagnostics and therapeutics. It commercializes Ghost Cytometry, a high-throughput fluorescence image-based cell-sorting platform that enables rapid, image-informed sorting and characterization of cells. The company targets research institutions, diagnostic developers and cell-therapy manufacturers seeking high-speed, image-based cytometry and sorting solutions.
Laboratory Equipment
Diagnostics
Bioinformatics
Genomelink operates a personal DNA cloud where people upload and store raw consumer genotyping data to receive trait and ancestry insights, discover related products, and contribute to research. The company provides consumer-facing reports and developer APIs that derive phenotype and ancestry information from uploaded 23andMe/Ancestry-style raw data and offers services to researchers and biotech partners. Genomelink is active in the US and Japan startup ecosystems, has participated in accelerators including Berkeley SkyDeck and StartX, and has been featured in Japan's METI J-Startup program.
Data & Analytics
Biotechnology
Genomics
SORA Technology develops and deploys drone and air-mobility solutions to address last-mile delivery and global health challenges. The company engineers unmanned aerial systems and operational services to support delivery of medical supplies, vector control and disaster-resilient logistics in developing countries. Its technology and services target governments, international health organizations and logistics providers seeking sustainable, resilient solutions for epidemic response and hard-to-reach communities.
Health Care
Delivery
Drones & UAVs
Cyfuse Biomedical develops Bio-3D printing technologies and instruments for regenerative medicine, best known for its Regenova Bio-3D Printer and the Kenzan spheroid-based bioprinting method. The company manufactures scaffold-free, cell-assembled tissue constructs by fusing multicellular spheroids to create transplantable tissues and in vitro models for drug discovery and research. Cyfuse primarily serves academic, clinical and commercial research customers worldwide from its headquarters in Tokyo, Japan.
Biotechnology
3D Printing
Regenerative Medicine
CYBERDYNE develops cybernics technologies and robotic medical devices that integrate humans and machines to assist movement and rehabilitation. The company is best known for its wearable Hybrid Assistive Limb (HAL) exoskeleton and related Cybernics interfaces and devices, which are used in medical rehabilitation, nursing care, industrial workplaces and daily living support. Founded as a university-originated venture in 2004, CYBERDYNE commercializes and socially implements Cybernics systems through clinical deployments, licensing and partnerships in Japan and international markets.
Robotics
Medical Devices
Exoskeletons & Wearable Robotics
CoreTissue BioEngineering develops medical devices derived from biological tissue using a proprietary decellularization technology to enable transplantation medicine without harvesting patients' own tissues. Its flagship pipeline is an artificial anterior cruciate ligament (ACL) for reconstruction that aims to replace the need to harvest autologous tendon grafts and reduce complications such as dysfunction, numbness, and infection. The company targets surgical and regenerative medicine markets in Japan and internationally, addressing high volumes of reconstructive procedures that currently rely on autografts.
Health Care
Regenerative Medicine
Medical Devices
Human Life CORD is a clinical-stage Japanese biotechnology company that develops off-the-shelf umbilical cord-derived allogeneic cell therapies. Its pipeline includes genetically unmodified mesenchymal stromal cell products intended to treat a range of indications from incurable disorders to aging-related diseases. The company focuses on using domestically sourced umbilical cord tissue to scale manufacturing, ensure quality and availability, and advance the next evolution of cellular medicine for an aging population.
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Global Vascular develops implantable vascular stents for peripheral artery disease (PAD), and its lead product, the BioStealth Stent, uses next-generation "stealth" technology to reduce foreign-body recognition and restenosis. The company's devices are engineered to tolerate repeated bending, twisting and deformation in lower-limb arteries and aim to provide durable revascularization for long-segment occlusions, including below-the-knee lesions. Global Vascular focuses on the global PAD market, addressing tens of millions of patients worldwide with the goal of improving limb salvage and long-term walking function in aging populations.
Health Care
Medical Devices
Gellycle develops proprietary hydrogel technology called TetraGel, a biocompatible soft material engineered for precise control over physical properties to enable applications in biological systems. Using a platform business model, the company is developing a pipeline of medical products including hemostatic agents, anti-adhesion materials and nerve-regeneration scaffolds, and has extended its hydrogel applications into industrial and agricultural markets. Gellycle positions itself as a pioneer in high-performance soft materials for medical engineering and biotechnology, aiming to replace hard materials with adaptable gels across clinical and commercial use cases.
Advanced Materials
Medical Devices
Biomaterials
CureApp is a Tokyo-based digital therapeutics company that develops software-based prescription medical applications and related digital health platforms for clinical use. The company has created a pipeline of therapeutic smartphone apps and platforms targeting conditions including non-alcoholic steatohepatitis (NASH), hypertension, and nicotine dependence, and it advances those products through clinical trials. Founded in 2014, CureApp works with healthcare institutions and industry partners in Japan to generate clinical evidence and pursue regulatory approval and commercial deployment of its prescription digital therapies.
Health Care
Software
Digital Health
KAKEHASHI is a healthcare technology company focused on pharmacy operations in Japan. It develops Musubi, a SaaS platform that automates and standardizes medicine record writing, and provides affiliated products including customer relationship management, business intelligence for pharmacy management, and instock management with AI demand forecasting. Its products target community pharmacies across Japan to support digital transformation and improve operational efficiency.
Pharmaceuticals
Software
Digital Health
Cellusion develops regenerative medicine therapies using induced pluripotent stem (iPS) cells focused on treating corneal endothelial diseases. The company is developing a proprietary minimally invasive cell therapy composed of corneal endothelial cells derived from iPS cells to reduce reliance on donor corneas and highly skilled surgeons. Its product targets patients with corneal blindness worldwide by enabling broader access to transplantation-like treatment options.
Health Care
Cell & Gene Therapy
Regenerative Medicine
Luxna Biotech is a preclinical-stage Japanese biotechnology company that develops antisense oligonucleotide (ASO) therapeutics using novel modified nucleoside chemistries and an original drug discovery platform called LuxiAPT. It leverages modified nucleosides invented at Osaka University alongside the LuxiAPT platform to discover and co-develop ASO drugs in collaboration with pharmaceutical companies and academic laboratories across multiple disease targets. The company places particular emphasis on neurological disorders and is pursuing both in-house programs and partnerships to develop therapies for spinal cord injury.
Pharmaceuticals
Drug Discovery
Biotechnology
LUCA Science is a preclinical-stage biopharmaceutical company developing a new class of mitochondrial therapies designed to restore cellular bioenergetics. It is building a platform to manufacture, store and deliver mitochondria-based drug candidates and related products for research and therapeutic development. The company targets a broad range of diseases with high unmet medical need in which mitochondrial dysfunction contributes to pathology.
Biopharma
Drug Discovery
Biotechnology
LPIXEL develops artificial intelligence and image-analysis software for life science and medical applications. The company provides advanced image-processing tools and platforms for researchers and professionals across medical, pharmaceutical and agricultural sectors, including solutions for medical image diagnosis and bioimage analysis. It collaborates with institutions such as the University of Tokyo and the National Cancer Center Japan to advance AI-powered medical diagnostic technologies.
Computer Vision
Medical Imaging
Medical AI
Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform enables precise engineering of megabase-scale genomic sequences directly within human cells, allowing creation of super-functionalized cells. Logomix positions these engineered cells for applications in cell therapy, regenerative medicine and other future cell-based therapeutics.
Regenerative Medicine
Cell & Gene Therapy
Synthetic Biology
AI Medical Service is a Japanese medical technology startup that develops artificial intelligence for endoscopy, specializing in automated classification of gastric cancer from endoscopic images and videos. Its flagship offering is an endoscopic AI diagnostic support system trained on a large dataset of over 150,000 endoscopic videos collected from around 100 medical institutions, designed to assist endoscopists by highlighting suspicious lesions and providing diagnostic classifications. The company targets hospitals and clinical endoscopy units in Japan and internationally and is working to expand its clinically integrated solutions into global clinical sites.
Health Care
Diagnostics
Medical AI
Instalimb develops and manufactures 3D-printed prosthetic and orthotic devices using 3D printing and machine-learning technologies. The company offers low-cost prostheses and orthoses produced via digital manufacturing workflows to reduce initial costs and delivery time compared with conventional devices. Instalimb targets global markets and seeks to provide affordable devices to tens of millions of people who cannot afford traditional prosthetics, offering prices reportedly below ten percent of conventional costs.
3D Printing
Medical Devices
Health Care
Integral Geometry Science develops measurement systems based on theories of reverse analysis of electromagnetic fields and the inverse analysis of scattered fields, claiming analytical solutions to inverse scattering and related inverse problems. It sells products including a tunnel performance inspection radar used by railway operators in the Kanto region and a non‑destructive electric current path imaging system for lithium‑ion batteries. The company is pursuing product development in battery diagnostics, breast cancer screening systems and advanced security gate solutions.
Medical Devices
Test & Measurement
Science & Engineering
Ashirase develops a wearable haptic navigation system for people with visual impairments that provides turn-by-turn walking guidance through tactile cues while leaving users' sight and hearing free. Its solution combines an ankle-worn vibrotactile device and a smartphone app that use GPS and routing data to guide outdoor walking and improve mobility and spatial awareness. The company targets visually impaired and low-vision users and related support organizations worldwide to expand independent mobility and encourage more active, confident walking.
Health Care
Medical Devices
Hardware
Alivas develops a first-in-the-world, minimally invasive medical device that offers a one-time treatment for patients with refractory constipation. The company originated from the Japan Biodesign fellowship and participates in Japan's METI J-Startup program to advance clinical translation of its technology. Its target market is patients with chronic refractory constipation and the broader gastroenterology medical device sector in Japan and international markets.
Medical Devices
Health Care
Allm provides mobile ICT solutions for the medical and welfare sectors, offering cloud-based communication and collaboration tools that support clinical workflows and emergency response. Its flagship product, Join, is a secure communication app for medical professionals used for clinical consultations, image sharing and care coordination, and the company also develops telemedicine and healthcare information systems. Headquartered in Tokyo, Japan, Allm markets its medical ICT solutions internationally and has deployed services in 28 countries as part of its global expansion.
Software
Digital Health
Health Care
Imbesideyou is a Tokyo, Japan startup that analyzes online communication video data using multimodal AI to visualize each person’s personality, engagement and mental health status. Its platform processes multimodal meeting and video data to deliver analytics and continuous-improvement tools that help organizations, remote teams and educators enhance online communication and mental well‑being. Founded by former NTT DATA engineers alongside an attorney and IIT graduates, the company has filed over 110 patents worldwide, reports over $130,000 monthly recurring revenue and has raised approximately $3 million in funding.
Mental Health
Multimodal AI
Artificial Intelligence
iHeart Japan develops allogeneic regenerative medical products derived from human induced pluripotent stem (iPS) cells targeting heart failure. It also provides in vitro research tools and cardiomyocyte platforms for cardiotoxicity screening and efficacy testing to pharmaceutical and biotechnology customers. The company aims to realize regenerative therapies that reduce reliance on heart transplantation and improve outcomes for patients with severe cardiac disease.
Regenerative Medicine
Biotechnology
Health Care
CGLIA is a global IT firm developing cloud-based software for research facilities, university medical centers, hospitals, and pharmaceutical companies contributing to the development of life-saving medications.
Clinical Research
Cloud Computing
Software
Hibernate
JavaScript
MySQL
Oracle
PostgreSQL
Spring Boot
SQL
TypeScript
+9 More
DailyRounds, part of M3 Inc, is a healthtech platform that provides web-based clinical learning, case-sharing, and medical updates for healthcare professionals, serving over 5 million doctors across nine countries.
Education
Digital Health
Health Care
Burp Suite
Firebase
Jira
Rest API
Postman
Charles Proxy
From prediction to disease-level simulation. Building organism-level models that simulate intervention response and drive high-value oncology decisions.
Medical AI
Biotechnology
Health Care
AWS
CI/CD
Docker
Go
Kubernetes
Snyk
Terraform
Unreal Engine
+22 More
Farmakopeika is a Russian retail pharmacy chain headquartered in Omsk and established in 2011. The company provides a comprehensive range of pharmaceutical products, including prescription medications, over-the-counter drugs, dietary supplements, medical equipment, and professional skincare cosmetics. It operates as a large-scale network with hundreds of locations across Siberia and the Ural regions, focusing on a discounter business model and professional pharmaceutical consultation services.
Commerce
Pharmaceuticals
Health Care
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 43 countries.
CRO & CDMO Services
Clinical Research
Health Care
The health coaching revolution starts hereLenus partners with the world's best health & fitness coaches to power their growth. We support the new generation in taking their coaching business to the next level. People who want to change the world.
Fitness
Coaching & Mentoring
Wellness
SQL
GDPR
1
open jobs
$71k
Salary
201-500
Team size
We are a strong, passionate team of more than 12,500 who take pride in caring for every person who comes through our doors. We lift each other up so we can provide the very best and safest care to those who need us most. Together. Every day. With the support of our university, we make up an academic medical center committed to excellence in patient care, innovation and training tomorrow's health care workforce.
Hospitals & Clinics
Higher Education
Health Care
Heartstrings Pet Hospice & In-Home Euthanasia is a network of dedicated veterinarians with a mission to ensure a tranquil end-of-life journey for every pet. We prioritize preserving the profound human-animal connection during this challenging phase and take pride in collaborating with caring and empathetic veterinarians. We firmly believe in providing aging pets with a serene, individualized end-of-life journey, guided by the understanding that pets are cherished family members.
Veterinary Medicine
Pet Care
Health Care
Herbalife is a global health and wellness community born to support you in living your best life. For over 40 years and in more than 90 countries, we've empowered millions of people to make real changes to their lives with our science-backed products, the support of a coach - what we call an Herbalife Distributor - and the opportunity to build a business. And we're just getting started.
Wellness
Dietary Supplements
Health & Wellness Products
Ansible
AWS
CI/CD
Docker
Grafana
Kubernetes
Prometheus
Python
+10 More
